COVID-19 in the years 2020 to 2022 in Germany: effects of comorbidities and co-medications based on a large-scale database analysis
Abstract Background The SARS-CoV-2 pandemic was a challenge for health care systems worldwide. People with pre-existing chronic diseases have been identified as vulnerable patient groups. Furthermore, some of the drugs used for these chronic diseases such as antihypertensive drugs have been discusse...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2025-02-01
|
| Seri Bilgileri: | BMC Public Health |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s12889-024-21110-7 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|